# Infinity Pharmaceuti Earnings Estimate

INFI | - USA Stock | ## USD 0.63 0.01 1.56% |

Many public companies, such as Infinity Pharmaceuti, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Infinity Pharmaceuti's earnings estimates, investors can diagnose different trends across Infinity Pharmaceuti's analyst sentiment over time as well as compare current estimates against different timeframes.

Infinity Pharmaceuti is projected to generate **-0.53**in earnings per share on the 31st of December 2021. Infinity Pharmaceuti earnings estimates module stress-tests analyst consensus about projected Infinity Pharmaceuti EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Please see Risk vs Return Analysis.

Infinity |

**M**, while Profit Margin is projected to decrease to (25.00) .

## Infinity Pharmaceuti Earnings Estimation Breakdown

Calculation of earning per share of Infinity Pharmaceuti is based on official Zacks consensus of 4 analysts regarding Infinity Pharmaceuti future annual earnings. Given the historical accuracy of 91.88%, the future earnings per share of Infinity Pharmaceuti is estimated to be -0.53 with the lowest and highest values of -0.55 and -0.52, respectively. Please note that this consensus of annual earnings estimates for Infinity Pharmaceuti is an estimate of EPS before non-recurring items and including employee stock options expenses Current EPS

-0.55 Lowest | Expected EPS | -0.52 Highest |

## Infinity Pharmaceuti Earnings Projection Consensus

Suppose the current estimates of Infinity Pharmaceuti's value are higher than the current market price of the Infinity Pharmaceuti stock. In this case, investors may conclude that Infinity Pharmaceuti is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Infinity Pharmaceuti's stock will quickly adjusts to the new information provided by the consensus estimate.

Number of Analysts | Historical Accuracy | Current EPS | EPS Estimate for 31st of December 2021 |

## 4 | ## 91.88% | ## -0.557 | ## -0.53 |

## Infinity Pharmaceuti Earnings History

Earnings estimate consensus by Infinity Pharmaceuti analysts from Wall Street is used by the market to judge Infinity Pharmaceuti's stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Infinity Pharmaceuti's upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.## Infinity Pharmaceuti Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA | ## (12.27 Million) |

**M**). The current Earning Before Interest and Taxes EBIT is estimated to decrease to about (48.6

**M**) The current Issuance Purchase of Equity Shares is estimated to increase to about 94

**M**, while Weighted Average Shares is projected to decrease to roughly 74.6

**M**.

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Infinity Pharmaceuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Infinity Pharmaceuti in the context of predictive analytics.

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Infinity Pharmaceuti. Your research has to be compared to or analyzed against Infinity Pharmaceuti's peers to derive any actionable benefits. When done correctly, Infinity Pharmaceuti's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Infinity Pharmaceuti.

Note that many institutional investors and large investment bankers can move markets due to the volume of Infinity assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Infinity Pharmaceuti. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Infinity stock price in the short term. ## Infinity Pharmaceuti Earnings per Share Projection vs Actual

Actual Earning per Share of Infinity Pharmaceuti refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Infinity Pharmaceuti predict the company's earnings will be in the future. The higher the earnings per share of Infinity Pharmaceuti, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.## Infinity Pharmaceuti Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Infinity Pharmaceuti, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Infinity Pharmaceuti should always be considered in relation to other companies to make a more educated investment decision.## Infinity Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Infinity Pharmaceuti's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.

Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|

2022-05-03 | 2022-03-31 | -0.13 | -0.14 | -0.01 | 7 | ||

2022-03-29 | 2021-12-31 | -0.13 | -0.13 | 0 | 0 | ||

2021-11-02 | 2021-09-30 | -0.1385 | -0.12 | 0.0185 | 13 | ||

2021-07-27 | 2021-06-30 | -0.1365 | -0.13 | 0.0065 | 4 | ||

2021-05-13 | 2021-03-31 | -0.1351 | -0.15 | -0.0149 | 11 | ||

2021-03-16 | 2020-12-31 | -0.1569 | -0.17 | -0.0131 | 8 | ||

2020-11-09 | 2020-09-30 | -0.152 | -0.16 | -0.008 | 5 | ||

2020-07-30 | 2020-06-30 | -0.2013 | -0.16 | 0.0413 | 20 | ||

2020-05-11 | 2020-03-31 | -0.1184 | -0.19 | -0.0716 | 60 | ||

2020-03-03 | 2019-12-31 | -0.2047 | -0.2 | 0.0047 | 2 | ||

2019-10-30 | 2019-09-30 | -0.1887 | -0.2 | -0.0113 | 5 | ||

2019-07-30 | 2019-06-30 | -0.1504 | -0.18 | -0.0296 | 19 | ||

2019-05-07 | 2019-03-31 | -0.16 | -0.24 | -0.08 | 50 | ||

2019-03-14 | 2018-12-31 | -0.1705 | -0.26 | -0.0895 | 52 | ||

2018-11-05 | 2018-09-30 | -0.1517 | 0.23 | 0.3817 | 251 | ||

2018-08-07 | 2018-06-30 | -0.1981 | -0.12 | 0.0781 | 39 | ||

2018-05-08 | 2018-03-31 | -0.1813 | -0.18 | 0.0013 | 0 | ||

2018-03-15 | 2017-12-31 | -0.2515 | -0.15 | 0.1015 | 40 | ||

2017-11-07 | 2017-09-30 | -0.2025 | -0.14 | 0.0625 | 30 | ||

2017-08-03 | 2017-06-30 | -0.2 | -0.34 | -0.14 | 70 | ||

2017-05-09 | 2017-03-31 | -0.2 | -0.21 | -0.01 | 5 | ||

2017-03-14 | 2016-12-31 | -0.4883 | -0.46 | 0.0283 | 5 | ||

2016-11-09 | 2016-09-30 | -0.8451 | -0.39 | 0.4551 | 53 | ||

2016-08-09 | 2016-06-30 | -0.8136 | -1.2 | -0.3864 | 47 | ||

2016-05-04 | 2016-03-31 | -0.8206 | -0.82 | 0.0006 | 0 | ||

2016-02-23 | 2015-12-31 | -0.8754 | -0.8 | 0.0754 | 8 | ||

2015-11-05 | 2015-09-30 | -0.55 | 0.84 | 1.39 | 252 | ||

2015-08-06 | 2015-06-30 | -1 | -0.78 | 0.22 | 22 | ||

2015-05-06 | 2015-03-31 | -1.68 | -1.91 | -0.23 | 13 | ||

2015-02-24 | 2014-12-31 | -0.98 | -0.83 | 0.15 | 15 | ||

2014-11-06 | 2014-09-30 | -0.86 | 2.03 | 2.89 | 336 | ||

2014-08-05 | 2014-06-30 | -0.84 | -0.78 | 0.06 | 7 | ||

2014-05-06 | 2014-03-31 | -0.83 | -0.87 | -0.04 | 4 | ||

2014-02-25 | 2013-12-31 | -0.87 | -0.68 | 0.19 | 21 | ||

2013-11-07 | 2013-09-30 | -0.74 | -0.71 | 0.03 | 4 | ||

2013-08-08 | 2013-06-30 | -0.62 | -0.68 | -0.06 | 9 | ||

2013-05-07 | 2013-03-31 | -0.69 | -0.57 | 0.12 | 17 | ||

2013-03-05 | 2012-12-31 | -0.87 | -1.15 | -0.28 | 32 | ||

2012-11-06 | 2012-09-30 | -0.57 | 0.52 | 1.09 | 191 | ||

2012-08-07 | 2012-06-30 | -0.38 | -0.54 | -0.16 | 42 | ||

2012-05-08 | 2012-03-31 | -0.37 | -0.4 | -0.03 | 8 | ||

2012-03-13 | 2011-12-31 | -0.42 | -0.53 | -0.11 | 26 | ||

2011-11-08 | 2011-09-30 | -0.42 | -0.45 | -0.03 | 7 | ||

2011-08-09 | 2011-06-30 | -0.36 | -0.44 | -0.08 | 22 | ||

2011-05-10 | 2011-03-31 | -0.36 | -0.09 | 0.27 | 75 | ||

2011-03-15 | 2010-12-31 | -0.39 | -0.53 | -0.14 | 35 | ||

2010-11-09 | 2010-09-30 | -0.76 | -0.81 | -0.05 | 6 | ||

2010-08-04 | 2010-06-30 | -0.32 | -0.24 | 0.08 | 25 | ||

2010-05-06 | 2010-03-31 | -0.34 | -0.32 | 0.02 | 5 | ||

2010-02-10 | 2009-12-31 | -0.42 | -0.3 | 0.12 | 28 | ||

2009-11-09 | 2009-09-30 | -0.44 | -0.36 | 0.08 | 18 | ||

2009-08-05 | 2009-06-30 | -0.49 | -0.43 | 0.06 | 12 | ||

2009-05-04 | 2009-03-31 | -0.07 | -0.15 | -0.08 | 114 | ||

2009-02-09 | 2008-12-31 | 1.01 | 2.11 | 1.1 | 108 | ||

2008-10-29 | 2008-09-30 | -0.54 | -0.63 | -0.09 | 16 | ||

2008-08-04 | 2008-06-30 | -0.45 | -0.57 | -0.12 | 26 | ||

2008-05-05 | 2008-03-31 | -0.36 | 0.02 | 0.38 | 105 | ||

2008-02-13 | 2007-12-31 | -0.24 | -0.4 | -0.16 | 66 | ||

2007-10-29 | 2007-09-30 | -0.33 | -0.1 | 0.23 | 69 | ||

2007-08-01 | 2007-06-30 | -0.29 | -0.21 | 0.08 | 27 | ||

2007-04-30 | 2007-03-31 | -0.27 | -0.15 | 0.12 | 44 | ||

2007-02-07 | 2006-12-31 | -0.54 | -0.27 | 0.27 | 50 | ||

2006-11-09 | 2006-09-30 | None | -0.8273 | None | 0 | ||

2006-08-09 | 2006-06-30 | None | -12.1457 | None | 0 | ||

2006-05-04 | 2006-03-31 | -0.56 | -1.4 | -0.84 | 150 | ||

2006-02-21 | 2005-12-31 | None | -1.2138 | None | 0 | ||

2005-11-01 | 2005-09-30 | -0.4 | -0.16 | 0.24 | 60 | ||

2005-08-02 | 2005-06-30 | -0.16 | -0.2 | -0.04 | 25 | ||

2005-05-03 | 2005-03-31 | -0.2 | -0.72 | -0.52 | 260 | ||

2005-03-01 | 2004-12-31 | 0.18 | 0.2 | 0.02 | 11 | ||

2004-11-02 | 2004-09-30 | 0.12 | 0.12 | 0 | 0 | ||

2004-07-20 | 2004-06-30 | 0.12 | 0.12 | 0 | 0 | ||

2004-04-20 | 2004-03-31 | 0.12 | 0.16 | 0.04 | 33 | ||

2004-02-10 | 2003-12-31 | 0.12 | 0.24 | 0.12 | 100 | ||

2003-10-21 | 2003-09-30 | 0.04 | 0.12 | 0.08 | 200 | ||

2003-07-22 | 2003-06-30 | 0.02 | 0.04 | 0.02 | 100 | ||

2003-04-22 | 2003-03-31 | -0.04 | 0.04 | 0.08 | 200 | ||

2003-02-11 | 2002-12-31 | -0.04 | 0.04 | 0.08 | 200 | ||

2002-10-22 | 2002-09-30 | -0.16 | -0.12 | 0.04 | 25 | ||

2002-07-23 | 2002-06-30 | -0.08 | -1.6 | -1.52 | 1900 | ||

2002-04-23 | 2002-03-31 | -0.12 | -0.12 | 0 | 0 | ||

2002-02-12 | 2001-12-31 | -0.25 | -0.28 | -0.03 | 12 | ||

2001-10-30 | 2001-09-30 | -1.08 | -1.08 | 0 | 0 | ||

2001-07-31 | 2001-06-30 | -0.12 | -0.16 | -0.04 | 33 | ||

2001-05-01 | 2001-03-31 | None | -0.36 | None | 0 | ||

2001-02-15 | 2000-12-31 | -0.09 | -0.04 | 0.05 | 55 | ||

2000-10-31 | 2000-09-30 | -0.2 | -0.12 | 0.08 | 40 |

## About Infinity Pharmaceuti Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Infinity Pharmaceuti earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Infinity Pharmaceuti estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Infinity Pharmaceuti fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'

Please read more on our stock advisor page.Last Reported | Projected for 2022 | |

Accumulated Retained Earnings Deficit | -811.6 M | -875.7 M |

Earning Before Interest and Taxes EBIT | -45.1 M | -48.6 M |

Earnings per Basic Share | (0.53) | (0.57) |

Earnings per Diluted Share | (0.53) | (0.57) |

Price to Earnings Ratio | (4.25) | (4.58) |

Earnings Before Interest Taxes and Depreciation Amortization EBITDA | -44.6 M | -48.1 M |

Earnings before Tax | -45.3 M | -48.8 M |

## Infinity Pharmaceuti Investors Sentiment

The influence of Infinity Pharmaceuti's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Infinity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.## Infinity Pharmaceuti Implied Volatility | 6.28 |

Infinity Pharmaceuti's implied volatility exposes the market's sentiment of Infinity Pharmaceuti stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Infinity Pharmaceuti's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Infinity Pharmaceuti stock will not fluctuate a lot when Infinity Pharmaceuti's options are near their expiration.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Infinity Pharmaceuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Infinity Pharmaceuti's short interest history, or implied volatility extrapolated from Infinity Pharmaceuti options trading.

## Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.## Build Optimal Portfolios

### Align your risk with return expectations

Please see Risk vs Return Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

## Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.

Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital | Go | |

Insider ScreenerFind insiders across different sectors to evaluate their impact on performance | Go | |

Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities | Go | |

Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | Go | |

Focused OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences | Go | |

Stock ScreenerFind equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | Go | |

Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation | Go |

The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.